We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Soliris (eculizumab) is a powerful medication for rare conditions like PNH, aHUS, gMG, and NMOSD. Learn about its common side effects such as headache, nausea, and fatigue, as well as serious risks including life-threatening meningococcal infections. Understand when to seek immediate medical attention and how to manage adverse reactions effectively.
Soliris (eculizumab) is a groundbreaking prescription medication used to treat several rare and severe autoimmune and blood disorders. It functions as a monoclonal antibody that targets and inhibits the C5 protein in the complement system, a part of the body's immune response. While highly effective in managing conditions like Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG) in certain adults, and Neuromyelitis Optica Spectrum Disorder (NMOSD) in specific adults, it's crucial for patients and caregivers to be fully aware of its potential side effects. Understanding these effects, from the most common to the potentially life-threatening, empowers patients to make informed decisions and work closely with their healthcare team to ensure the safest possible treatment journey. This comprehensive guide will delve into the various side effects associated with Soliris, offering insights into their symptoms, potential causes, management strategies, and when to seek medical attention.
To understand Soliris's side effects, it helps to know how it works. Soliris is a complement inhibitor. The complement system is a complex network of proteins in the blood that plays a vital role in the immune system's defense against pathogens and in clearing damaged cells. However, in conditions like PNH, aHUS, gMG, and NMOSD, the complement system can become dysregulated, leading to uncontrolled activation that damages healthy cells and tissues. Soliris specifically binds to the C5 protein, preventing its cleavage into C5a and C5b, thereby blocking the downstream activation of the terminal complement pathway. This action helps to prevent the destruction of red blood cells in PNH, kidney damage in aHUS, muscle weakness in gMG, and neurological damage in NMOSD. By modulating the immune system, Soliris can significantly improve the quality of life for patients with these debilitating diseases. However, this modulation also comes with a trade-off: a potential compromise in the body's ability to fight certain infections.
Like most medications, Soliris can cause a range of side effects, some of which are more frequently reported than others. These common side effects are generally mild to moderate in severity and often improve as your body adjusts to the medication. However, it's essential to monitor them and report any concerns to your healthcare provider.
Headache is one of the most frequently reported side effects of Soliris. It can range from a mild, dull ache to a more significant throbbing sensation. While often manageable, severe or persistent headaches should always be discussed with your doctor.
Gastrointestinal upset, including nausea and occasionally vomiting, can occur with Soliris treatment.
Many patients experience fatigue or a general feeling of tiredness while on Soliris.
Due to Soliris's effect on the immune system, patients may be more susceptible to common infections like colds and other upper respiratory tract infections.
Aches and pains in muscles and the back are also reported side effects.
Changes in bowel habits, including diarrhea, can occur.
Low-grade fever can sometimes be a side effect, but it's crucial to differentiate it from a fever indicating a serious infection.
While less common, some side effects of Soliris can be serious and require immediate medical attention. It is imperative for patients and caregivers to be vigilant for these symptoms and understand the necessary actions to take.
This is the most critical and potentially life-threatening side effect associated with Soliris. The drug carries a black box warning from the FDA, indicating a serious risk of meningococcal infections caused by Neisseria meningitidis bacteria. Soliris works by inhibiting the complement system, which is a key part of the body's defense against encapsulated bacteria, including meningococcus.
Beyond meningococcal disease, Soliris can increase the risk of other serious infections, particularly those caused by encapsulated bacteria. This includes infections like pneumonia and sepsis.
Some patients may experience reactions during or shortly after receiving a Soliris infusion.
Though rare, severe allergic reactions, including anaphylaxis, can occur.
While Soliris is used to treat conditions that can involve blood clots (like PNH), there's still a risk of developing new or worsening blood clots, especially if treatment is interrupted.
If Soliris treatment is stopped, particularly in patients with PNH, aHUS, gMG, or NMOSD, there is a risk of severe exacerbation of the underlying disease. This is often referred to as a

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026